Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
140.00
-3.50 (-2.44%)
Jul 11, 2025, 1:30 PM CST

Lumosa Therapeutics Revenue

Lumosa Therapeutics had revenue of 8.90M TWD in the quarter ending March 31, 2025, with 99.33% growth. This brings the company's revenue in the last twelve months to 43.59M, down -18.38% year-over-year. In the year 2024, Lumosa Therapeutics had annual revenue of 39.15M, down -31.21%.

Revenue (ttm)
43.59M
Revenue Growth
-18.38%
P/S Ratio
542.23
Revenue / Employee
1.01M
Employees
43
Market Cap
23.63B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 39.15M -17.76M -31.21%
Dec 31, 2023 56.92M 30.27M 113.63%
Dec 31, 2022 26.64M 9.28M 53.45%
Dec 31, 2021 17.36M -4.29M -19.81%
Dec 31, 2020 21.65M -150.39M -87.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition